Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Argentine Parliament discusses endosulfan

The Argentine Parliament hosted a public discussion on the use of the organochlorine insecticide, endosulfan, in the country. Medics and representatives of the general public who live close to fields treated with the insecticide have called for its prohibition. Soybean growers and industry representatives were among those at the meeting. The executive director of the agrochemical industry association, the Casafe, Juan Cruz Jaime, called for a recess on the question until the fifth Conference of the Parties to the Rotterdam Convention on prior informed consent (PIC) takes place in June, Santa Fe newspaper Notife reports. The fertiliser and pesticide industry association, the Ciafa, warned that there was no substitute for its use on cotton. The government is to participate at the June meeting, at which a decision is expected on the future trade in endosulfan. EU member states have agreed to support the inclusion of endosulfan on the PIC list (see this issue). Endosulfan is the most commonly used insecticide in Argentina, Notife says.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG004527

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel